The main goal of the Conference is to introduce the current status of New Alternative Methods and their potential to support Tobacco Harm Reduction worldwide. The aim of the CORESTA conference is also to foster scientific engagement between CORESTA members and THR international community to facilitate the discussion around reduced risk devices and support evidence-based tobacco regulatory policies.
"It is surprising to note that there are very few studies that can be considered truly informative of the risk-benefit ratio of new technologies with reduced risk in terms of their impact on health. We are proud to say that CoEHAR research ranks among the best in the current scientific landscape"
With the enrollment of the first patient, the project has officially started, thanks to the collaboration of international renew partners: the Addendo Clinic (Catania), the University of Modena and Reggio Emilia, the University of Bologna, and research centres in Warsaw (Poland), Chisinau (Moldova) and Bandung (Indonesia).
CoEHAR, the Center of Excellence for the acceleration of Harm Reduction of the University of Catania, has launched a two-year study, the Diasmoke project, to investigate whether vaping or using E-cigarettes reduces the risk of cardiovascular (heart and circulation) disease as compared to normal smoking.
For the first time, CoEHAR researchers used the saccharin test transit time to compare the data on the regeneration of respiratory cilia among current, former and never smokers, electronic cigarette users and heated tobacco products users. The results suggest that combustion-free nicotine delivery technologies are unlikely to have detrimental effects on mucociliary clearance
The aim of the study is to investigate different in vitro toxicity methods for the assessment of ENDs toxicity. According to the Italian researchers, the most used assay, the neutral red uptake, should be combined with different tools (enlisted in the study) to better identifies the toxicity of the products and can avoid approximate and incorrect evaluation
Professor Riccardo Polosa discuss in an interview on Medical Tribune the results of his study: heated tobacco products produce fewer exacerbations and better quality of life in COPD patients compared to conventional cigarettes.
The REPLICA Project is proud to announce the third Harmonization meeting involving researchers and international partners. The two-day session is going to be held on May 26 and May 28 2021
A new study by CoEHAR, the "Role of Cigarette Smoke on Angiotensin-Converting Enzyme-2 Protein Membrane Expression in Bronchial Epithelial Cells Using an Air-Liquid Interface Model" investigates the molecular mechanisms that regulate the expression of the ACE2 enzyme, involved in Covid-19 infection
The new study by CoEHAR, "Nicotine dosimetry and stability in cambridge filter PADs (CFPs) following different smoking regime protocols and storage conditions", provided new guidelines for future multicentric studies in the low-risk products
We will send you direct emails, without intermediary services, you can withdraw any time.
Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.